BLISS GVS PHARMA share price has zoomed 10% and is presently trading at Rs 113.8.
Meanwhile, the BSE HEALTHCARE index is at 37,866.5 (up 1.2%).
Among the top gainers in the BSE HEALTHCARE index today are ASTRAZENECA PHARMA (up 11.9%) and Lupin (up 8.2%).
ERIS LIFESCIENCES (down 1.5%) and SUVEN PHARMACEUTICALS (down 1.2%) are among the top losers today.
Over the last one year, BLISS GVS PHARMA has moved up from Rs 80.1 to Rs 113.8, registering a gain of Rs 33.7 (up 42.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 37,866.5, registering a gain of 47.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Lupin (up 97.7%), Cadila Healthcare (up 97.1%) and Glenmark Pharma (up 96.8%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 80,049.7 (up 0.1%).
The top gainers among the BSE Sensex today are Tata Motors (up 2.7%) and HCl Tech. (up 2.7%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.
In the meantime, NSE Nifty is at 24,304.7 (up 0.1%). Tata Motors and HCl Tech. are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 80,049.7, registering a gain of 14,844.6 points (up 22.8%).
BLISS GVS PHARMA net profit fell 241.7% YoY to Rs -49 million for the quarter ended March 2024, compared to a profit of Rs 35 million a year ago. Net sales rose 7.2% to Rs 1,981 million during the period as against Rs 1,848 million in January-March 2023.
For the year ended March 2023, BLISS GVS PHARMA reported 231.8% increase in net profit to Rs 767 million compared to net profit of Rs 231 million during FY22. Revenue of the company grew 0.6% to Rs 7,516 million during FY23.
The current Price to earnings ratio of BLISS GVS PHARMA, based on rolling 12 month earnings, stands at 14.6.
Equitymaster requests your view! Post a comment on "BLISS GVS PHARMA Gains 10%; BSE HEALTHCARE Index Up 1.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!